Barclays upgraded Lumentum Holdings Inc (NASDAQ:LITE) to "Overweight" from "Underweight," setting a price target of $125, given significant growth potential driven by surging demand from hyperscale customers.
Lumentum's (NASDAQ:LITE) stock rose about 6% premarket on Friday after Barclays upgraded the shares to Overweight from Underweight. The firm also raised the price target to $125 from $80 on the shares of the company,
Nasdaq (NASDAQ:NDAQ – Get Free Report) had its price objective reduced by research analysts at Barclays from $97.00 to $96.00 in a research note issued to investors on Monday,Benzinga reports. The brokerage presently has an “overweight” rating on the financial services provider’s stock.
Barclays analyst Benjamin Budish maintained a Buy rating on Nasdaq (NDAQ – Research Report) today and set a price target of $96.00. The
Wall St rallies as Intel, Nvidia, and SLB lead gains. Banks surge 6%, while Truist climbs on strong profits. Investors eye Trump’s policy outlook.
In a report released today, Thomas O’Malley from Barclays maintained a Hold rating on Lam Research (LRCX – Research Report), with a price
Shares of semiconductor giant Broadcom (NASDAQ: AVGO) were up Friday, gaining 2.7% as of noon ET, but were up as much as 3.6% earlier in the day. The rise comes as the S&P 500 (SNPINDEX: ^GSPC) and Nasdaq Composite (NASDAQINDEX: ^IXIC) were up 1% and 1.
Tesla’s (NASDAQ:TSLA) business priorities for 2025 revolve around several key areas: achieving renewed volume growth (driven by the launch of a
Investment firm Barclays laid out its thoughts for the technology space in 2025 in a research note on Thursday, covering everything from Apple (NASDAQ:AAPL) to networking to hardware and more. On Apple,
Barclays (LON:BARC) analysts raised their price target for Netflix (NASDAQ:NFLX) stock to $715 from $550 but maintained an Underweight rating, citing significant challenges for the streaming giant in meeting the lofty
In a report released today, Eric Morgan from Barclays maintained a Buy rating on Saia (SAIA – Research Report), with a price target of $600.00.